Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  dovitinib lactate
Find trials that include:  Any drugs shown
Results 1-6 of 6 for your search:
Start Over
Dovitinib Lactate in Combination With Anastrozole, Exemestane, or Letrozole in Treating Patients With Hormone-Receptor Positive Metastatic Breast Cancer
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2010-535, NCI-2013-00749, NCT01484041
Dovitinib Lactate in Treating Patients with Relapsed HER2-Negative Stage IV Inflammatory Breast Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 2010-0296, NCI-2011-00299, NCT01262027
Dovitinib Lactate in Treating Patients with Previously Treated Advanced Non-Small Cell Lung Cancer or Colorectal Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: UCDCC#231, NCI-2013-01182, 344991, 344991-6, CTKI258AUS21T, NCT01676714
Dovitinib Lactate in Treating Patients With Refractory or Stage 0-I Bladder Cancer With FGFR3 Mutations or Overexpression
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: GU12-157, NCI-2013-00610, 1211009949, CTKI258AUS17T, NCT01732107
Erlotinib Hydrochloride and Dovitinib Lactate in Treating Patients With Metastatic Non-Small Cell Lung Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: LUN0044, NCI-2011-03333, NCT01515969
Start Over